166 related articles for article (PubMed ID: 24871365)
1. MicroRNA function in the profibrogenic interplay upon chronic liver disease.
Huang J; Yu X; Fries JW; Zhang L; Odenthal M
Int J Mol Sci; 2014 May; 15(6):9360-71. PubMed ID: 24871365
[TBL] [Abstract][Full Text] [Related]
2. Hepatic stellate cells require a stiff environment for myofibroblastic differentiation.
Olsen AL; Bloomer SA; Chan EP; Gaça MD; Georges PC; Sackey B; Uemura M; Janmey PA; Wells RG
Am J Physiol Gastrointest Liver Physiol; 2011 Jul; 301(1):G110-8. PubMed ID: 21527725
[TBL] [Abstract][Full Text] [Related]
3. HepG2.2.15-derived exosomes facilitate the activation and fibrosis of hepatic stellate cells.
Gao Y; Li L; Zhang SN; Mang YY; Zhang XB; Feng SM
World J Gastroenterol; 2024 May; 30(19):2553-2563. PubMed ID: 38817658
[TBL] [Abstract][Full Text] [Related]
4. Autophagy: a multifaceted partner in liver fibrosis.
Mallat A; Lodder J; Teixeira-Clerc F; Moreau R; Codogno P; Lotersztajn S
Biomed Res Int; 2014; 2014():869390. PubMed ID: 25254217
[TBL] [Abstract][Full Text] [Related]
5. Research Progress on the Effect of Autophagy and Exosomes on Liver Fibrosis.
Du Y; Zhu S; Zeng H; Wang Z; Huang Y; Zhou Y; Zhang W; Zhu J; Yang C
Curr Stem Cell Res Ther; 2024; 19(6):785-797. PubMed ID: 37102476
[TBL] [Abstract][Full Text] [Related]
6. The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families.
Murakami Y; Toyoda H; Tanaka M; Kuroda M; Harada Y; Matsuda F; Tajima A; Kosaka N; Ochiya T; Shimotohno K
PLoS One; 2011 Jan; 6(1):e16081. PubMed ID: 21283674
[TBL] [Abstract][Full Text] [Related]
7. RNA sequencing reveals changes in the microRNAome of transdifferentiating hepatic stellate cells that are conserved between human and rat.
Sabater L; Locatelli L; Oakley F; Hardy T; French J; Robinson SM; Sen G; Mann DA; Mann J
Sci Rep; 2020 Dec; 10(1):21708. PubMed ID: 33303921
[TBL] [Abstract][Full Text] [Related]
8. IL-33-ST2 Axis in Liver Disease: Progression and Challenge.
Sun Z; Chang B; Gao M; Zhang J; Zou Z
Mediators Inflamm; 2017; 2017():5314213. PubMed ID: 29180837
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of liver fibrosis and its role in liver cancer.
Dhar D; Baglieri J; Kisseleva T; Brenner DA
Exp Biol Med (Maywood); 2020 Jan; 245(2):96-108. PubMed ID: 31924111
[TBL] [Abstract][Full Text] [Related]
10. Survival of the Fittest: Clonal Selection of Somatic Mutations Reveals Targets to Abate Chronic Liver Injury.
Niemi NM; Debosch BJ
Gastroenterology; 2024 May; 166(5):936-937. PubMed ID: 38340873
[No Abstract] [Full Text] [Related]
11. MicroRNA in hepatic fibrosis and cirrhosis.
Xin X; Zhang Y; Liu X; Xin H; Cao Y; Geng M
Front Biosci (Landmark Ed); 2014 Jun; 19(8):1418-24. PubMed ID: 24896361
[TBL] [Abstract][Full Text] [Related]
12. The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis.
Hu J; Chen C; Liu Q; Liu B; Song C; Zhu S; Wu C; Liu S; Yu H; Yao D; Kang J; Zhu L
Clin Sci (Lond); 2015 Aug; 129(4):305-17. PubMed ID: 25728779
[TBL] [Abstract][Full Text] [Related]
13. The role of microRNAs in hepatitis C virus replication and related liver diseases.
Lee CH; Kim JH; Lee SW
J Microbiol; 2014 Jun; 52(6):445-51. PubMed ID: 24871972
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-200a controls Nrf2 activation by target Keap1 in hepatic stellate cell proliferation and fibrosis.
Yang JJ; Tao H; Hu W; Liu LP; Shi KH; Deng ZY; Li J
Cell Signal; 2014 Nov; 26(11):2381-9. PubMed ID: 25049078
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA responses to environmental liver carcinogens: Biological and clinical significance.
Nicolaidou V; Koufaris C
Clin Chim Acta; 2015 May; 445():25-33. PubMed ID: 25773117
[TBL] [Abstract][Full Text] [Related]
16. The role of miRNAs in the regulation of inflammatory processes during hepatofibrogenesis.
Roy S; Benz F; Luedde T; Roderburg C
Hepatobiliary Surg Nutr; 2015 Feb; 4(1):24-33. PubMed ID: 25713802
[TBL] [Abstract][Full Text] [Related]
17. microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis.
Csak T; Bala S; Lippai D; Satishchandran A; Catalano D; Kodys K; Szabo G
Liver Int; 2015 Feb; 35(2):532-41. PubMed ID: 25040043
[TBL] [Abstract][Full Text] [Related]
18. miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review.
Di Martino MT; Arbitrio M; Caracciolo D; Cordua A; Cuomo O; Grillone K; Riillo C; Caridà G; Scionti F; Labanca C; Romeo C; Siciliano MA; D'Apolito M; Napoli C; Montesano M; Farenza V; Uppolo V; Tafuni M; Falcone F; D'Aquino G; Calandruccio ND; Luciano F; Pensabene L; Tagliaferri P; Tassone P
Mol Ther Nucleic Acids; 2022 Mar; 27():1191-1224. PubMed ID: 35282417
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review.
Morishita A; Oura K; Tadokoro T; Fujita K; Tani J; Masaki T
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33572780
[TBL] [Abstract][Full Text] [Related]
20. Exogenous Therapeutics of Microrna-29a Attenuates Development of Hepatic Fibrosis in Cholestatic Animal Model through Regulation of Phosphoinositide 3-Kinase p85 Alpha.
Yang YL; Wang FS; Lin HY; Huang YH
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
